vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and USA TODAY Co., Inc. (TDAY). Click either name above to swap in a different company.

USA TODAY Co., Inc. is the larger business by last-quarter revenue ($548.5M vs $493.8M, roughly 1.1× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 3.6%, a 3.2% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -4.0%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -7.4%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

USA Today Co., Inc., formerly known as Gannett, is an American mass media holding company headquartered in New York City. It is the largest U.S. newspaper publisher as measured by total daily circulation.

MD vs TDAY — Head-to-Head

Bigger by revenue
TDAY
TDAY
1.1× larger
TDAY
$548.5M
$493.8M
MD
Growing faster (revenue YoY)
MD
MD
+2.3% gap
MD
-1.7%
-4.0%
TDAY
Higher net margin
MD
MD
3.2% more per $
MD
6.8%
3.6%
TDAY
Faster 2-yr revenue CAGR
MD
MD
Annualised
MD
-0.1%
-7.4%
TDAY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MD
MD
TDAY
TDAY
Revenue
$493.8M
$548.5M
Net Profit
$33.7M
$19.9M
Gross Margin
Operating Margin
9.9%
Net Margin
6.8%
3.6%
Revenue YoY
-1.7%
-4.0%
Net Profit YoY
10.5%
EPS (diluted)
$0.40
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
TDAY
TDAY
Q1 26
$548.5M
Q4 25
$493.8M
$585.0M
Q3 25
$492.9M
$560.8M
Q2 25
$468.8M
$584.9M
Q1 25
$458.4M
$571.6M
Q4 24
$502.4M
$621.3M
Q3 24
$511.2M
$612.4M
Q2 24
$504.3M
$639.8M
Net Profit
MD
MD
TDAY
TDAY
Q1 26
$19.9M
Q4 25
$33.7M
$-30.1M
Q3 25
$71.7M
$-39.2M
Q2 25
$39.3M
$78.4M
Q1 25
$20.7M
$-7.3M
Q4 24
$30.5M
$64.3M
Q3 24
$19.4M
$-19.7M
Q2 24
$-153.0M
$13.7M
Gross Margin
MD
MD
TDAY
TDAY
Q1 26
Q4 25
41.5%
Q3 25
37.2%
Q2 25
38.5%
Q1 25
37.6%
Q4 24
39.5%
Q3 24
38.6%
Q2 24
38.8%
Operating Margin
MD
MD
TDAY
TDAY
Q1 26
Q4 25
9.9%
7.4%
Q3 25
13.8%
-3.9%
Q2 25
12.8%
-1.6%
Q1 25
7.0%
1.7%
Q4 24
7.8%
1.0%
Q3 24
6.6%
-1.0%
Q2 24
-31.3%
1.1%
Net Margin
MD
MD
TDAY
TDAY
Q1 26
3.6%
Q4 25
6.8%
-5.1%
Q3 25
14.5%
-7.0%
Q2 25
8.4%
13.4%
Q1 25
4.5%
-1.3%
Q4 24
6.1%
10.4%
Q3 24
3.8%
-3.2%
Q2 24
-30.3%
2.1%
EPS (diluted)
MD
MD
TDAY
TDAY
Q1 26
$0.12
Q4 25
$0.40
$-0.09
Q3 25
$0.84
$-0.27
Q2 25
$0.46
$0.42
Q1 25
$0.24
$-0.05
Q4 24
$0.37
$0.47
Q3 24
$0.23
$-0.14
Q2 24
$-1.84
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
TDAY
TDAY
Cash + ST InvestmentsLiquidity on hand
$375.2M
$85.2M
Total DebtLower is stronger
$570.5M
$726.8M
Stockholders' EquityBook value
$865.9M
$141.4M
Total Assets
$2.2B
$1.8B
Debt / EquityLower = less leverage
0.66×
5.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
TDAY
TDAY
Q1 26
$85.2M
Q4 25
$375.2M
$90.2M
Q3 25
$340.1M
$75.2M
Q2 25
$224.7M
$88.5M
Q1 25
$99.0M
$85.9M
Q4 24
$229.9M
$106.3M
Q3 24
$103.8M
$101.8M
Q2 24
$19.4M
$98.9M
Total Debt
MD
MD
TDAY
TDAY
Q1 26
$726.8M
Q4 25
$570.5M
$954.2M
Q3 25
$577.2M
$971.8M
Q2 25
$583.9M
$988.9M
Q1 25
$590.5M
$1.0B
Q4 24
$597.1M
$1.1B
Q3 24
$992.1M
Q2 24
$1.0B
Stockholders' Equity
MD
MD
TDAY
TDAY
Q1 26
$141.4M
Q4 25
$865.9M
$155.1M
Q3 25
$890.7M
$194.0M
Q2 25
$833.8M
$237.1M
Q1 25
$789.2M
$150.1M
Q4 24
$764.9M
$153.1M
Q3 24
$732.5M
$240.5M
Q2 24
$706.5M
$249.8M
Total Assets
MD
MD
TDAY
TDAY
Q1 26
$1.8B
Q4 25
$2.2B
$1.8B
Q3 25
$2.2B
$1.9B
Q2 25
$2.1B
$2.0B
Q1 25
$2.0B
$2.0B
Q4 24
$2.2B
$2.0B
Q3 24
$2.1B
$2.1B
Q2 24
$2.0B
$2.1B
Debt / Equity
MD
MD
TDAY
TDAY
Q1 26
5.14×
Q4 25
0.66×
6.15×
Q3 25
0.65×
5.01×
Q2 25
0.70×
4.17×
Q1 25
0.75×
6.71×
Q4 24
0.78×
7.05×
Q3 24
4.13×
Q2 24
4.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
TDAY
TDAY
Operating Cash FlowLast quarter
$114.1M
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
TDAY
TDAY
Q1 26
Q4 25
$114.1M
$43.4M
Q3 25
$137.3M
Q2 25
$137.2M
Q1 25
$-117.5M
$23.3M
Q4 24
$133.0M
$9.0M
Q3 24
$91.8M
Q2 24
$107.0M
Free Cash Flow
MD
MD
TDAY
TDAY
Q1 26
$6.4M
Q4 25
$30.8M
Q3 25
Q2 25
Q1 25
$9.8M
Q4 24
$-3.8M
Q3 24
Q2 24
FCF Margin
MD
MD
TDAY
TDAY
Q1 26
1.2%
Q4 25
5.3%
Q3 25
Q2 25
Q1 25
1.7%
Q4 24
-0.6%
Q3 24
Q2 24
Capex Intensity
MD
MD
TDAY
TDAY
Q1 26
2.4%
Q4 25
2.2%
Q3 25
Q2 25
Q1 25
2.4%
Q4 24
2.1%
Q3 24
Q2 24
Cash Conversion
MD
MD
TDAY
TDAY
Q1 26
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
0.14×
Q3 24
4.72×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

TDAY
TDAY

Print and commercial$286.6M52%
Digital$261.9M48%

Related Comparisons